{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T15:21:30Z","timestamp":1777648890469,"version":"3.51.4"},"reference-count":92,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.beem.2011.09.003","type":"journal-article","created":{"date-parts":[[2012,4,9]],"date-time":"2012-04-09T14:37:20Z","timestamp":1333982240000},"page":"145-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Metabolic insights from extreme human insulin resistance phenotypes"],"prefix":"10.1016","volume":"26","author":[{"given":"Anna","family":"Stears","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"O\u2019Rahilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert K.","family":"Semple","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David B.","family":"Savage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.beem.2011.09.003_bib1","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/ATVBAHA.108.179564","article-title":"The LDL receptor","volume":"29","author":"Goldstein","year":"2009","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"25","key":"10.1016\/j.beem.2011.09.003_bib2","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1056\/NEJM197606172942509","article-title":"Familial hypercholesterolemia: a genetic defect in the low-density lipoprotein receptor","volume":"294","author":"Brown","year":"1976","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1016\/j.beem.2011.09.003_bib3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/204748730000700505","article-title":"The insulin resistance syndrome: impact on lipoprotein metabolism and atherothrombosis","volume":"7","author":"Ginsberg","year":"2000","journal-title":"Journal of Cardiovascular Risk"},{"issue":"12","key":"10.1016\/j.beem.2011.09.003_bib4","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","article-title":"Banting lecture 1988. Role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"issue":"16","key":"10.1016\/j.beem.2011.09.003_bib5","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.beem.2011.09.003_bib6","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2337\/diacare.28.9.2289","article-title":"The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes","volume":"28","author":"Kahn","year":"2005","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.beem.2011.09.003_bib7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2796.2010.02325.x","article-title":"The metabolic syndrome: time to get off the merry-go-round?","volume":"269","author":"Reaven","year":"2011","journal-title":"Journal of Internal Medicine"},{"issue":"4","key":"10.1016\/j.beem.2011.09.003_bib8","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1210\/er.2010-0020","article-title":"Genetic syndromes of severe insulin resistance","volume":"32","author":"Semple","year":"2011","journal-title":"Endocrine Reviews"},{"issue":"3","key":"10.1016\/j.beem.2011.09.003_bib9","first-page":"190","article-title":"Congenital syndromes of severe insulin resistance","volume":"8","author":"Huang-Doran","year":"2011","journal-title":"Pediatric Endocrinology Reviews"},{"issue":"3","key":"10.1016\/j.beem.2011.09.003_bib10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1677\/JOE-10-0272","article-title":"Lipodystrophy: metabolic insights from a rare disorder","volume":"207","author":"Huang-Doran","year":"2010","journal-title":"Journal of Endocrinology"},{"key":"10.1016\/j.beem.2011.09.003_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000316893","article-title":"Human lipodystrophies: genetic and acquired diseases of adipose tissue","volume":"19","author":"Capeau","year":"2010","journal-title":"Endocrine Development"},{"key":"10.1016\/j.beem.2011.09.003_bib12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000111067","article-title":"A clinical approach to severe insulin resistance","volume":"11","author":"Savage","year":"2007","journal-title":"Endocrine Development"},{"issue":"3","key":"10.1016\/j.beem.2011.09.003_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrendo.2010.199","article-title":"Lipodystrophy: pathophysiology and advances in treatment","volume":"7","author":"Fiorenza","year":"2011","journal-title":"Nature Reviews Endocrinology"},{"issue":"3","key":"10.1016\/j.beem.2011.09.003_bib14","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1365-2265.2010.03810.x","article-title":"What is the best management strategy for patients with severe insulin resistance?","volume":"73","author":"Semple","year":"2010","journal-title":"Clinical Endocrinology"},{"issue":"11","key":"10.1016\/j.beem.2011.09.003_bib15","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1007\/s00125-009-1508-3","article-title":"Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals","volume":"52","author":"Finucane","year":"2009","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.beem.2011.09.003_bib16","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2337\/dc07-2194","article-title":"Plasma adiponectin as a marker of insulin receptor dysfunction: clinical utility in severe insulin resistance","volume":"31","author":"Semple","year":"2008","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.beem.2011.09.003_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cmet.2011.06.003","article-title":"Hormonal regulation of hepatic glucose production in health and disease","volume":"14","author":"Lin","year":"2011","journal-title":"Cell Metabolism"},{"issue":"25","key":"10.1016\/j.beem.2011.09.003_bib18","doi-asserted-by":"crossref","first-page":"10162","DOI":"10.1073\/pnas.1019268108","article-title":"Hyperinsulinemia leads to uncoupled insulin regulation of the GLUT4 glucose transporter and the FoxO1 transcription factor","volume":"108","author":"Gonzalez","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"22","key":"10.1016\/j.beem.2011.09.003_bib19","doi-asserted-by":"crossref","first-page":"17235","DOI":"10.1074\/jbc.M110.118620","article-title":"Insulin and insulin-like growth factor-1 receptors act as ligand-specific amplitude modulators of a common pathway regulating gene transcription","volume":"285","author":"Boucher","year":"2010","journal-title":"Journal of Biological Chemistry"},{"issue":"9","key":"10.1016\/j.beem.2011.09.003_bib20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5070\/D37MF6G290","article-title":"Acanthosis nigricans: a practical approach to evaluation and management","volume":"14","author":"Higgins","year":"2008","journal-title":"Dermatology Online Journal"},{"issue":"3","key":"10.1016\/j.beem.2011.09.003_bib21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/1523-1747.ep12616668","article-title":"Expression of growth hormone receptor, insulin-like growth factor 1 (IGF-1) and IGF-1 receptor mRNA and proteins in human skin","volume":"99","author":"Tavakkol","year":"1992","journal-title":"The Journal of Investigative Dermatology"},{"issue":"6 Suppl","key":"10.1016\/j.beem.2011.09.003_bib22","doi-asserted-by":"crossref","first-page":"82S","DOI":"10.1111\/1523-1747.ep12462293","article-title":"Excess insulin binding to insulin-like growth factor receptors: proposed mechanism for acanthosis nigricans","volume":"98","author":"Cruz","year":"1992","journal-title":"The Journal of Investigative Dermatology"},{"issue":"6","key":"10.1016\/j.beem.2011.09.003_bib23","doi-asserted-by":"crossref","first-page":"500","DOI":"10.2337\/diacare.11.6.500","article-title":"Selective insulin action on skin, ovary, and heart in insulin-resistant states","volume":"11","author":"Geffner","year":"1988","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.beem.2011.09.003_bib24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2165\/00128071-200405030-00008","article-title":"Acanthosis nigricans associated with insulin resistance:pathophysiology and management","volume":"5","author":"Hermanns-Le","year":"2004","journal-title":"American Journal of Clinical Dermatology"},{"issue":"1","key":"10.1016\/j.beem.2011.09.003_bib25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-0028-1108009","article-title":"The interplay of insulin-like growth factors, gonadotropins, and endocrine disruptors in ovarian follicular development and function","volume":"27","author":"Kwintkiewicz","year":"2009","journal-title":"Seminars in Reproductive Medicine"},{"issue":"6","key":"10.1016\/j.beem.2011.09.003_bib26","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1210\/en.2009-1439","article-title":"Insulin-like growth factor-I activates extracellularly regulated kinase to regulate the p450 side-chain cleavage insulin-like response element in granulosa cells","volume":"151","author":"Denner","year":"2010","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.beem.2011.09.003_bib27","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1210\/edrv-13-3-566","article-title":"Mutations in the insulin receptor gene","volume":"13","author":"Taylor","year":"1992","journal-title":"Endocrine Reviews"},{"issue":"6","key":"10.1016\/j.beem.2011.09.003_bib28","first-page":"1533","article-title":"Insulin-mediated pseudoacromegaly: clinical and biochemical characterization of a syndrome of selective insulin resistance","volume":"76","author":"Flier","year":"1993","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"2","key":"10.1016\/j.beem.2011.09.003_bib29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cmet.2007.12.009","article-title":"Selective versus total insulin resistance: a pathogenic paradox","volume":"7","author":"Brown","year":"2008","journal-title":"Cell Metabolism"},{"issue":"1","key":"10.1016\/j.beem.2011.09.003_bib30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1097-2765(05)00010-9","article-title":"Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob\/ob mice","volume":"6","author":"Shimomura","year":"2000","journal-title":"Molecular Cell"},{"issue":"1","key":"10.1016\/j.beem.2011.09.003_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/79111","article-title":"Failure of adipocyte differentiation causes type II diabetes mellitus?","volume":"26","author":"Danforth","year":"2000","journal-title":"Nature Genetics"},{"issue":"12","key":"10.1016\/j.beem.2011.09.003_bib32","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1172\/JCI8305","article-title":"Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle","volume":"105","author":"Kim","year":"2000","journal-title":"Journal of Clinical Investigation"},{"issue":"3","key":"10.1016\/j.beem.2011.09.003_bib33","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.bbalip.2009.12.006","article-title":"Adipose tissue expandability, lipotoxicity and the metabolic syndrome\u2013an allostatic perspective","volume":"1801","author":"Virtue","year":"2010","journal-title":"Biochimica et Biophysica Acta"},{"issue":"7196","key":"10.1016\/j.beem.2011.09.003_bib34","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nature06902","article-title":"Dynamics of fat cell turnover in humans","volume":"453","author":"Spalding","year":"2008","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.beem.2011.09.003_bib35","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1373\/clinchem.2007.100156","article-title":"The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences","volume":"54","author":"de Ferranti","year":"2008","journal-title":"Clinical Chemistry"},{"issue":"2","key":"10.1016\/j.beem.2011.09.003_bib36","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.23719","article-title":"Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites","volume":"52","author":"Neuschwander-Tetri","year":"2010","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.beem.2011.09.003_bib37","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1007\/s00125-010-1684-1","article-title":"Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture","volume":"53","author":"DeFronzo","year":"2009","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.beem.2011.09.003_bib38","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nm0410-400","article-title":"Diacylglycerol-mediated insulin resistance","volume":"16","author":"Erion","year":"2010","journal-title":"Nature Medicine"},{"issue":"9733","key":"10.1016\/j.beem.2011.09.003_bib39","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/S0140-6736(10)60408-4","article-title":"Lipid-induced insulin resistance: unravelling the mechanism","volume":"375","author":"Samuel","year":"2010","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.beem.2011.09.003_bib40","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1152\/physrev.00024.2006","article-title":"Disordered lipid metabolism and the pathogenesis of insulin resistance","volume":"87","author":"Savage","year":"2007","journal-title":"Physiological Reviews"},{"issue":"4","key":"10.1016\/j.beem.2011.09.003_bib41","doi-asserted-by":"crossref","first-page":"910","DOI":"10.2337\/diabetes.52.4.910","article-title":"Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma","volume":"52","author":"Savage","year":"2003","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.beem.2011.09.003_bib42","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1056\/NEJMoa1007487","article-title":"Perilipin deficiency and autosomal dominant partial lipodystrophy","volume":"364","author":"Gandotra","year":"2011","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.beem.2011.09.003_bib43","first-page":"12","article-title":"Human frameshift mutations affecting the carboxyl terminus of perilipin increase lipolysis by failing to sequester the adipose triglyceride lipase (ATGL) coactivator, AB-hydrolase containing 5 (ABHD5)","volume":"12","author":"Gandotra","year":"2011","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.beem.2011.09.003_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4020-9173-5_1","article-title":"Challenges and novel approaches in the epidemiological study of early life influences on later disease","volume":"646","author":"Davey Smith","year":"2009","journal-title":"Advances in Experimental Medicine & Biology"},{"issue":"4746","key":"10.1016\/j.beem.2011.09.003_bib45","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1126\/science.3513311","article-title":"A receptor-mediated pathway for cholesterol homeostasis","volume":"232","author":"Brown","year":"1986","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.beem.2011.09.003_bib46","doi-asserted-by":"crossref","first-page":"E462","DOI":"10.1152\/ajpendo.00064.2004","article-title":"Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population","volume":"288","author":"Szczepaniak","year":"2005","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"issue":"6037","key":"10.1016\/j.beem.2011.09.003_bib47","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: old questions and new insights","volume":"332","author":"Cohen","year":"2011","journal-title":"Science"},{"issue":"2 Suppl. 1","key":"10.1016\/j.beem.2011.09.003_bib48","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/hep.20973","article-title":"Nonalcoholic fatty liver disease: from steatosis to cirrhosis","volume":"43","author":"Farrell","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.beem.2011.09.003_bib49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/ATVBAHA.107.147538","article-title":"Fatty liver: a novel component of the metabolic syndrome","volume":"28","author":"Kotronen","year":"2008","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"5","key":"10.1016\/j.beem.2011.09.003_bib50","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"Journal of Clinical Investigation"},{"issue":"3","key":"10.1016\/j.beem.2011.09.003_bib51","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1210\/jc.2004-1494","article-title":"Energy expenditure and adaptive responses to an acute hypercaloric fat load in humans with lipodystrophy","volume":"90","author":"Savage","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"8","key":"10.1016\/j.beem.2011.09.003_bib52","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1007\/s00125-008-1040-x","article-title":"Adipose tissue fatty acid metabolism in insulin-resistant men","volume":"51","author":"Bickerton","year":"2008","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.beem.2011.09.003_bib53","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2337\/db10-0867","article-title":"Downregulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat deposition?","volume":"60","author":"McQuaid","year":"2011","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.beem.2011.09.003_bib54","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00125-005-0070-x","article-title":"Non-esterified fatty acid concentrations are independently associated with hepatic steatosis in obese subjects","volume":"49","author":"Holt","year":"2006","journal-title":"Diabetologia"},{"issue":"31","key":"10.1016\/j.beem.2011.09.003_bib55","doi-asserted-by":"crossref","first-page":"12587","DOI":"10.1073\/pnas.0705408104","article-title":"The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome","volume":"104","author":"Petersen","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/j.beem.2011.09.003_bib56","first-page":"315","article-title":"Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis","volume":"119","author":"Semple","year":"2009","journal-title":"Journal of Clinical Investigation"},{"issue":"8","key":"10.1016\/j.beem.2011.09.003_bib57","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1073\/pnas.1000323107","article-title":"mTORC1 activates SREBP-1c and uncouples lipogenesis from gluconeogenesis","volume":"107","author":"Laplante","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/j.beem.2011.09.003_bib58","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cmet.2011.06.002","article-title":"Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-Dependent and Independent pathways","volume":"14","author":"Yecies","year":"2011","journal-title":"Cell Metabolism"},{"issue":"1","key":"10.1016\/j.beem.2011.09.003_bib59","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm.2277","article-title":"Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin","volume":"17","author":"Holland","year":"2011","journal-title":"Nature Medicine"},{"key":"10.1016\/j.beem.2011.09.003_bib60","article-title":"Genetic syndromes of severe insulin resistance","volume":"2","author":"Semple","year":"22011","journal-title":"Endocrine Reviews"},{"issue":"6","key":"10.1016\/j.beem.2011.09.003_bib61","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.2337\/db06-1665","article-title":"Paradoxical elevation of high-molecular weight adiponectin in acquired extreme insulin resistance due to insulin receptor antibodies","volume":"56","author":"Semple","year":"2007","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.beem.2011.09.003_bib62","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1210\/jc.2009-2286","article-title":"Hypoadiponectinemia\u2013cause or consequence of human \"insulin resistance","volume":"95","author":"Cook","year":"2010","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"3","key":"10.1016\/j.beem.2011.09.003_bib63","doi-asserted-by":"crossref","first-page":"E613","DOI":"10.1152\/ajpendo.90288.2008","article-title":"Hyperglycemia prevents the suppressive effect of hyperinsulinemia on plasma adiponectin levels in healthy humans","volume":"295","author":"Blumer","year":"2008","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"issue":"1","key":"10.1016\/j.beem.2011.09.003_bib64","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1534-5807(02)00199-5","article-title":"Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance","volume":"3","author":"Bluher","year":"2002","journal-title":"Developmental Cell."},{"issue":"5","key":"10.1016\/j.beem.2011.09.003_bib65","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1074\/jbc.M505311200","article-title":"Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists","volume":"281","author":"Nawrocki","year":"2006","journal-title":"Journal of Biological Chemistry"},{"issue":"7","key":"10.1016\/j.beem.2011.09.003_bib66","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nm724","article-title":"Diet-induced insulin resistance in mice lacking adiponectin\/ACRP30","volume":"8","author":"Maeda","year":"2002","journal-title":"Nature Medicine"},{"issue":"29","key":"10.1016\/j.beem.2011.09.003_bib67","doi-asserted-by":"crossref","first-page":"25863","DOI":"10.1074\/jbc.C200251200","article-title":"Disruption of adiponectin causes insulin resistance and neointimal formation","volume":"277","author":"Kubota","year":"2002","journal-title":"Journal of Biological Chemistry"},{"issue":"6","key":"10.1016\/j.beem.2011.09.003_bib68","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1530\/EJE-09-0492","article-title":"Association of the +45T\u00a0>\u00a0G and +276G\u00a0>\u00a0T polymorphisms in the adiponectin gene with insulin resistance in nondiabetic Greek women","volume":"161","author":"Melistas","year":"2009","journal-title":"European Journal of Endocrinology"},{"issue":"12","key":"10.1016\/j.beem.2011.09.003_bib69","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.2337\/db08-0700","article-title":"Common variants in the adiponectin gene (ADIPOQ) associated with plasma adiponectin levels, type 2 diabetes, and diabetes-related quantitative traits: the Framingham Offspring Study","volume":"57","author":"Hivert","year":"2008","journal-title":"Diabetes"},{"issue":"27","key":"10.1016\/j.beem.2011.09.003_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399406000147","article-title":"Adiponectin, type 2 diabetes and the metabolic syndrome: lessons from human genetic studies","volume":"8","author":"Vasseur","year":"2006","journal-title":"Expert Reviews in Molecular Medicine"},{"issue":"21","key":"10.1016\/j.beem.2011.09.003_bib71","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1093\/hmg\/11.21.2607","article-title":"Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians","volume":"11","author":"Vasseur","year":"2002","journal-title":"Human Molecular Genetics"},{"issue":"7","key":"10.1016\/j.beem.2011.09.003_bib72","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.2337\/diabetes.51.7.2325","article-title":"Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome","volume":"51","author":"Kondo","year":"2002","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.beem.2011.09.003_bib73","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/01.ATV.0000208363.85388.8f","article-title":"Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome in Japanese men","volume":"26","author":"Matsushita","year":"2006","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"27","key":"10.1016\/j.beem.2011.09.003_bib74","first-page":"2676","article-title":"Sex hormone-binding globulin and risk of type 2 diabetes","volume":"361","author":"Nestler","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1016\/j.beem.2011.09.003_bib75","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1056\/NEJMoa0804381","article-title":"Sex hormone-binding globulin and risk of type 2 diabetes in women and men","volume":"361","author":"Ding","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1016\/j.beem.2011.09.003_bib76","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/hmg\/ddp522","article-title":"Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes","volume":"19","author":"Perry","year":"2009","journal-title":"Human Molecular Genetics"},{"issue":"10","key":"10.1016\/j.beem.2011.09.003_bib77","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.2337\/diabetes.51.10.2944","article-title":"Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes","volume":"51","author":"Kelley","year":"2002","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.beem.2011.09.003_bib78","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1172\/JCI25151","article-title":"Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents","volume":"115","author":"Morino","year":"2005","journal-title":"Journal of Clinical Investigation"},{"issue":"1","key":"10.1016\/j.beem.2011.09.003_bib79","doi-asserted-by":"crossref","first-page":"E49","DOI":"10.1152\/ajpendo.00317.2009","article-title":"Deficiency of electron transport chain in human skeletal muscle mitochondria in type 2 diabetes mellitus and obesity","volume":"298","author":"Ritov","year":"2009","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"issue":"1","key":"10.1016\/j.beem.2011.09.003_bib80","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2337\/diabetes.54.1.8","article-title":"Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes","volume":"54","author":"Ritov","year":"2005","journal-title":"Diabetes"},{"issue":"5622","key":"10.1016\/j.beem.2011.09.003_bib81","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1126\/science.1082889","article-title":"Mitochondrial dysfunction in the elderly: possible role in insulin resistance","volume":"300","author":"Petersen","year":"2003","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.beem.2011.09.003_bib82","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1056\/NEJMoa031314","article-title":"Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes","volume":"350","author":"Petersen","year":"2004","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1016\/j.beem.2011.09.003_bib83","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1371\/journal.pmed.0040154","article-title":"Muscle mitochondrial ATP synthesis and glucose transport\/phosphorylation in type 2 diabetes","volume":"4","author":"Szendroedi","year":"2007","journal-title":"PLoS Medicine"},{"issue":"3","key":"10.1016\/j.beem.2011.09.003_bib84","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.bbalip.2009.09.011","article-title":"Mitochondrial dysfunction and lipotoxicity","volume":"1801","author":"Schrauwen","year":"2010","journal-title":"Biochimica et Biophysica Acta"},{"issue":"1","key":"10.1016\/j.beem.2011.09.003_bib85","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00125-006-0475-1","article-title":"Impaired in\u00a0vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects","volume":"50","author":"Schrauwen-Hinderling","year":"2007","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.beem.2011.09.003_bib86","first-page":"698","article-title":"Muscular mitochondrial dysfunction and type 2 diabetes mellitus","volume":"10","author":"Schrauwen-Hinderling","year":"2007","journal-title":"Current Opinion in Clinical Nutrition and Metabolic Care"},{"issue":"11","key":"10.1016\/j.beem.2011.09.003_bib87","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.2337\/db08-0391","article-title":"Lower intrinsic ADP-stimulated mitochondrial respiration underlies in\u00a0vivo mitochondrial dysfunction in muscle of male type 2 diabetic patients","volume":"57","author":"Phielix","year":"2008","journal-title":"Diabetes"},{"issue":"Suppl. 2(2)","key":"10.1016\/j.beem.2011.09.003_bib88","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.2337\/db06-S002","article-title":"Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction","volume":"55","author":"Morino","year":"2006","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.beem.2011.09.003_bib89","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1210\/er.2009-0027","article-title":"The role of mitochondria in the pathogenesis of type 2 diabetes","volume":"31","author":"Patti","year":"2010","journal-title":"Endocrine Reviews."},{"issue":"2","key":"10.1016\/j.beem.2011.09.003_bib90","first-page":"789","article-title":"Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice","volume":"118","author":"Bonnard","year":"2008","journal-title":"Journal of Clinical Investigation"},{"issue":"6","key":"10.1016\/j.beem.2011.09.003_bib91","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1172\/JCI46405","article-title":"Mitochondrial dysfunction in patients with primary congenital insulin resistance","volume":"121","author":"Sleigh","year":"2011","journal-title":"Journal of Clinical Investigation"},{"issue":"1","key":"10.1016\/j.beem.2011.09.003_bib92","first-page":"77","article-title":"Bioenergetics of intact human muscle. A 31P nuclear magnetic resonance study","volume":"1","author":"Taylor","year":"1983","journal-title":"Molecular Biology & Medicine"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X11001230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X11001230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:44:46Z","timestamp":1761497086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X11001230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":92,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S1521690X11001230"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2011.09.003","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic insights from extreme human insulin resistance phenotypes","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2011.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}